AVN 63.60 Increased By ▲ 1.85 (3%)
BOP 8.65 Decreased By ▼ -0.08 (-0.92%)
CHCC 124.50 Decreased By ▼ -2.00 (-1.58%)
DCL 8.85 Decreased By ▼ -0.06 (-0.67%)
DGKC 101.70 Decreased By ▼ -0.56 (-0.55%)
EFERT 61.65 Decreased By ▼ -4.90 (-7.36%)
EPCL 42.99 Decreased By ▼ -0.26 (-0.6%)
FCCL 20.40 Decreased By ▼ -0.05 (-0.24%)
FFL 13.67 Increased By ▲ 0.08 (0.59%)
HASCOL 13.39 Decreased By ▼ -0.08 (-0.59%)
HBL 128.88 Increased By ▲ 0.38 (0.3%)
HUBC 79.40 Increased By ▲ 0.54 (0.68%)
HUMNL 7.10 Increased By ▲ 0.72 (11.28%)
JSCL 21.85 Increased By ▲ 0.02 (0.09%)
KAPCO 27.60 Increased By ▲ 0.11 (0.4%)
KEL 3.60 No Change ▼ 0.00 (0%)
LOTCHEM 11.75 Decreased By ▼ -0.03 (-0.25%)
MLCF 36.51 Decreased By ▼ -0.74 (-1.99%)
OGDC 93.80 Increased By ▲ 1.44 (1.56%)
PAEL 30.35 Decreased By ▼ -0.10 (-0.33%)
PIBTL 11.78 Decreased By ▼ -0.01 (-0.08%)
PIOC 83.35 Decreased By ▼ -1.50 (-1.77%)
POWER 9.20 Increased By ▲ 0.05 (0.55%)
PPL 84.45 Increased By ▲ 1.91 (2.31%)
PSO 187.55 Increased By ▲ 1.06 (0.57%)
SNGP 43.00 Increased By ▲ 0.50 (1.18%)
STPL 13.30 No Change ▼ 0.00 (0%)
TRG 51.33 Increased By ▲ 0.23 (0.45%)
UNITY 23.34 Increased By ▲ 0.04 (0.17%)
WTL 0.99 No Change ▼ 0.00 (0%)
BR100 4,131 Increased By ▲ 19.61 (0.48%)
BR30 20,689 Increased By ▲ 66.76 (0.32%)
KSE100 39,863 Increased By ▲ 230.84 (0.58%)
KSE30 16,752 Increased By ▲ 58.2 (0.35%)
Business

Pakistan’s CCL Pharmaceuticals acquire UAE’s StratHealth Pharma

  • The acquisition of business by CCL will enhance its footprint to an attractive GCC region along side strengthening its consumer and OTC portfolio, read the company statement.
16 Nov 2020

Pakistan’s leading pharmaceuticals firm CCL Pharmaceuticals has acquired 51 percent stake in UAE-based StratHealth Pharma.

StratGurus Group of Companies signed an MoU with Pakistan’s leading CCL Pharmaceuticals that acquired the major shareholder’s status of Dubai-based StratHealth Pharma.

Strathealth Pharma is an upcoming healthcare company based in UAE with an extensive range of Pharma and consumer healthcare products and a promising pipeline. The company offers a strong portfolio of personal care including women health and wound management besides having a nutraceuticals range.

The acquisition of business by CCL will enhance its footprint to an attractive GCC region along side strengthening its consumer and OTC portfolio, read the company statement.

The acquisition will offer a variety of treatment choices to healthcare and consumers in GGC Market in line with CCL’s mission of enabling healthy, happy lives.

At the MoU signing, Dr Tabassum Khan, chairman of StratGurus Group of Companies said: “This acquisition is a well-needed boost for the local pharmaceutical industry. This will strengthen the product portfolio of StratHealth Pharma and provide access to a broader range of healthcare products for consumers in the Gulf countries.”

The chairman of CCL, Kashif Sajjad Sheikh said: “We are privileged to acquire a reputable organisation such as StratHealth Pharma and look forward to strengthening our operations, creating new employment opportunities and providing a comprehensive portfolio of products that will enhance healthier lifestyles and elevate healthcare in the region.”

It is pertinent to mention that CCL Pharmaceuticals is a leading multinational pharmaceutical company with over 50 years of experience in the pursuit of health and wellbeing. CCL’s heritage gives it the strength and capability to help enable healthy and happy communities.